Literature DB >> 19643532

Virotherapy against malignant glioma stem cells.

Mahua Dey1, Ilya V Ulasov, Maciej S Lesniak.   

Abstract

Glioblastoma multiforme, the most common primary intracranial malignancy, is associated with very poor outcome despite advances in surgical techniques and chemo- and radiation therapy. Many novel treatment modalities are being investigated with varying amount of success. Evolution of cancer stem cell hypothesis provides a new venue for developmental therapeutics. In this review, we highlight the literature regarding the existence of glioma stem cells and their characteristics. We also discuss the potential for virotherapy, a novel therapeutic approach utilizing conditionally replicative viruses, to directly target this population of self-renewing cancer stem cells. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh：

Year:  2009        PMID： 19643532      PMCID： PMC2824041          DOI： 10.1016/j.canlet.2009.04.045

Source DB:  PubMed          Journal:  Cancer Lett        ISSN： 0304-3835            Impact factor:   8.679


  91 in total

1.  A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma.

Authors:  Manfred Westphal; Dana C Hilt; Enoch Bortey; Patrick Delavault; Robert Olivares; Peter C Warnke; Ian R Whittle; Juha Jääskeläinen; Zvi Ram
Journal:  Neuro Oncol       Date:  2003-04       Impact factor: 12.300

2.  Prospective identification of tumorigenic breast cancer cells.

Authors:  Muhammad Al-Hajj; Max S Wicha; Adalberto Benito-Hernandez; Sean J Morrison; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

Review 3.  Stem cells, cancer, and cancer stem cells.

Authors:  T Reya; S J Morrison; M F Clarke; I L Weissman
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

4.  Potential of the conditionally replicative adenovirus Ad5-Delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapy.

Authors:  Martine L M Lamfers; Jacques Grill; Clemens M F Dirven; Victor W Van Beusechem; Birgit Geoerger; Jaap Van Den Berg; Ramon Alemany; Juan Fueyo; David T Curiel; Gilles Vassal; Herbert M Pinedo; W Peter Vandertop; Winald R Gerritsen
Journal:  Cancer Res       Date:  2002-10-15       Impact factor: 12.701

5.  CXCR4 is a major chemokine receptor on glioma cells and mediates their survival.

Authors:  Yan Zhou; Peter H Larsen; Chunhai Hao; V Wee Yong
Journal:  J Biol Chem       Date:  2002-10-17       Impact factor: 5.157

Review 6.  Oncolytic adenoviruses for malignant glioma therapy.

Authors:  Hong Jiang; Charles Conrad; Juan Fueyo; Candelaria Gomez-Manzano; Ta-Jen Liu
Journal:  Front Biosci       Date:  2003-05-01

7.  Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolished.

Authors:  Victor W van Beusechem; Jacques Grill; D C Jeroen Mastenbroek; Thomas J Wickham; Peter W Roelvink; Hidde J Haisma; Martine L M Lamfers; Clemens M F Dirven; Herbert M Pinedo; Winald R Gerritsen
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

Review 8.  Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials.

Authors:  L A Stewart
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

9.  Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway.

Authors:  Juan Fueyo; Ramon Alemany; Candelaria Gomez-Manzano; Gregory N Fuller; Asadullah Khan; Charles A Conrad; Ta-Jen Liu; Hong Jiang; Michael G Lemoine; Kaori Suzuki; Raymond Sawaya; David T Curiel; W K Alfred Yung; Frederick F Lang
Journal:  J Natl Cancer Inst       Date:  2003-05-07       Impact factor: 13.506

10.  Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro.

Authors:  Tatyana N Ignatova; Valery G Kukekov; Eric D Laywell; Oleg N Suslov; Frank D Vrionis; Dennis A Steindler
Journal:  Glia       Date:  2002-09       Impact factor: 7.452
View more
  15 in total

Review 1.  Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.

Authors:  Kurt M Kroeger; A K M Ghulam Muhammad; Gregory J Baker; Hikmat Assi; Mia K Wibowo; Weidong Xiong; Kader Yagiz; Marianela Candolfi; Pedro R Lowenstein; Maria G Castro
Journal:  Discov Med       Date:  2010-10       Impact factor: 2.970

Review 2.  Repurposing some older drugs that cross the blood-brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma.

Authors:  Dayle Rundle-Thiele; Richard Head; Leah Cosgrove; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2015-10-30       Impact factor: 4.335

3.  Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma.

Authors:  Atique U Ahmed; Bart Thaci; Nikita G Alexiades; Yu Han; Shuo Qian; Feifei Liu; Irina V Balyasnikova; Ilya Y Ulasov; Karen S Aboody; Maciej S Lesniak
Journal:  Mol Ther       Date:  2011-05-31       Impact factor: 11.454

4.  Isorhapontigenin suppresses growth of patient-derived glioblastoma spheres through regulating miR-145/SOX2/cyclin D1 axis.

Authors:  Zhou Xu; Xingruo Zeng; Jiawei Xu; Derek Xu; Jingxia Li; Honglei Jin; Guosong Jiang; Xiaosi Han; Chuanshu Huang
Journal:  Neuro Oncol       Date:  2015-12-17       Impact factor: 12.300

Review 5.  Evolution of malignant glioma treatment: from chemotherapy to vaccines to viruses.

Authors:  Richard Lee Price; Ennio Antonio Chiocca
Journal:  Neurosurgery       Date:  2014-08       Impact factor: 4.654

6.  Glioma Stem Cells but Not Bulk Glioma Cells Upregulate IL-6 Secretion in Microglia/Brain Macrophages via Toll-like Receptor 4 Signaling.

Authors:  Omar Dzaye; Feng Hu; Katja Derkow; Verena Haage; Philipp Euskirchen; Christoph Harms; Seija Lehnardt; Michael Synowitz; Susanne A Wolf; Helmut Kettenmann
Journal:  J Neuropathol Exp Neurol       Date:  2016-03-30       Impact factor: 3.685

7.  Antiglioma oncolytic virotherapy: unattainable goal or a success story in the making?

Authors:  Mahua Dey; Brenda Auffinger; Maciej S Lesniak; Atique U Ahmed
Journal:  Future Virol       Date:  2013-07       Impact factor: 1.831

Review 8.  Primary brain tumors, neural stem cell, and brain tumor cancer cells: where is the link?

Authors:  Isabelle Germano; Victoria Swiss; Patrizia Casaccia
Journal:  Neuropharmacology       Date:  2010-01-01       Impact factor: 5.250

9.  Dendritic Cell-Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma.

Authors:  Mahua Dey; Alan L Chang; Jason Miska; Derek A Wainwright; Atique U Ahmed; Irina V Balyasnikova; Peter Pytel; Yu Han; Alex Tobias; Lingjiao Zhang; Jian Qiao; Maciej S Lesniak
Journal:  J Immunol       Date:  2015-05-29       Impact factor: 5.422

10.  LncRNA MIR155HG Promotes Temozolomide Resistance by Activating the Wnt/β-Catenin Pathway Via Binding to PTBP1 in Glioma.

Authors:  Xin He; Jie Sheng; Wei Yu; Kejian Wang; Shujuan Zhu; Qian Liu
Journal:  Cell Mol Neurobiol       Date:  2020-06-11       Impact factor: 5.046
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.